Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks edge higher as BoE holds rates

Thu, 04th Oct 2012 11:47

- Middle-East tensions dampen sentiment- BoE holds rates; ECB decision eyed- Investors await US jobless claimsAfter swinging into negative territory briefly, the FTSE 100 was back above water by Thursday lunchtime ahead of interest rate decisions in the UK and Europe. Meanwhile, investors were showing some caution this morning on the back of tensions in the Middle East.Speaking earlier this morning, market strategist Ishaq Siddiqi from ETX Capital said: "European markets surrendered morning gains ahead of the BOE and ECB monthly policy meetings as increasing tensions between Turkey and Syria prompted investors to cut risk positions. Turkey firing at targets in Syria and unconfirmed reports that Iran was mobilising troops on the Turkish-Iranian border curbed upside momentum."However, buying had picked up by midday ahead of the announcement by the Bank of England. As expected, the BoE's Monetary Policy Committee (MPC) maintained the Bank Rate at 0.5% and the asset purchase programme (other known as quantitative easing, or QE) at £375bn.According to Chris Crowe from Barclays Research, "Further easing in November [...] seems likely in the absence of significant upside news in the interim. We are fairly confident in forecasting an additional £50bn in QE will be announced at the November meeting. We also continue to forecast a 25 basis point rate cut, but this is a much more marginal call."The European Central Bank (ECB) is also expected to remain in 'wait-and-see' mode when it reveals its policy decision after midday. Analysts believe that the ECB will wait for Spain to make the next move considering that it already announced its bond purchase plan for ailing countries that request aid. The key interest rate currently stands at 0.75% after it was cut by 25 basis points early in the year. The deposit rate is at 0%. Markets will also be keeping a close eye on weekly jobless claims figures from the US out before the market open in New York (around 13:30 London time). Consensus estimates are for claims to rise to 370k last week from 359k the week before. US stock futures are pointing to gains when Wall Street opens also ahead of the release of the Federal Open Market Committee (FOMC) minutes.In Eurozone news, Spain's Treasury sold €3.99bn in two-,three- and five-year debt, the top end of its targeted range. While bid-to-cover ratios improved across all maturities, the yields on offer fell.The Troika has said it expects the Greek economy to contract by 5% in 2013, notably worse than the 3.8% fall in gross domestic product (GDP) expected by Greece's own government.FTSE 100: Tate & Lyle gains on broker upgradeSweeteners and food products group Tate & Lyle was the high riser in early trading after Credit Suisse raised its recommendation for the stock from 'neutral' to 'outperform'. The broker said: "There is no easy way to value Tate & Lyle, but it does seem to us to be a better business for all the changes we have seen and that this is not reflected in the share price (which is down 8% year to date versus a staples sector up 18%)."According to reports, BHP Billiton is among the companies talking to Petrobras about buying a stake in its's Gulf of Mexico oilfields. The miner was trading in the red today after analysts at Morgan Stanley lowered their price target for the shares from 2,180p to 2,100p.Pharmaceuticals behemoth GlaxoSmithKline gained after saying its joint venture company, Shionogi-ViiV Healthcare, has completed an initial clinical registration package for dolutegravir, its treatment for HIV patients. Supermarket peers Tesco and Sainsbury were among the stocks in the red following their results and trading update yesterday, respectively. Exane BNP Paribas reduced its target price for Tesco this morning from 325p to 300p and reiterated its 'underperform' rating on the shares. FTSE 250: Halfords jumps on solid Q2, new CEOCar and bike parts retailer Halfords jumped after appointing a new Chief Executive Officer following the abrupt departure of David Wild in the summer, as it revealed that full-year profits would be at the top end of guidance after a strong second quarter. The company expects pre-tax profit to be in the region of £40-42m in the first half on the back of its second quarter performance and an acceleration of operating cost investment. The consensus estimate prior to the announcement stood at £35.8m. Both Panmure Gordon and Seymour Pierce raised their target prices for the shares today.Fashion chain Ted Baker was in demand after saying that the reaction to its autumn/winter collections has been positive as it unveiled a solid first-half trading performance. Transport company FirstGroup was firmer following the 20.7% drop the day before after the Department for Transport cancelled the decision to award the group the West Coast rail franchise. UBS this morning has upgraded the stock from 'sell' to 'neutral' after yesterday's big fall, but said that there are still "major challenges ahead". Morgan Stanley also raised its rating to 'equal weight', while HSBC downgraded to 'underweight'.FTSE 100 - RisersNext (NXT) 3,584.00p +2.43%Carnival (CCL) 2,369.00p +2.42%Tate & Lyle (TATE) 689.00p +2.15%Smiths Group (SMIN) 1,060.00p +2.02%ARM Holdings (ARM) 600.00p +1.87%Weir Group (WEIR) 1,794.00p +1.82%InterContinental Hotels Group (IHG) 1,668.00p +1.77%Tullow Oil (TLW) 1,420.00p +1.72%Kingfisher (KGF) 269.00p +1.70%Hargreaves Lansdown (HL.) 654.50p +1.55%FTSE 100 - FallersJohnson Matthey (JMAT) 2,370.00p -1.94%Tesco (TSCO) 322.40p -1.69%BHP Billiton (BLT) 1,911.00p -1.65%Amec (AMEC) 1,137.00p -1.13%BP (BP.) 434.15p -1.12%G4S (GFS) 265.20p -1.04%Eurasian Natural Resources Corp. (ENRC) 313.60p -0.85%Rio Tinto (RIO) 2,912.50p -0.75%Royal Dutch Shell 'B' (RDSB) 2,209.00p -0.70%Morrison (Wm) Supermarkets (MRW) 282.90p -0.67%FTSE 250 - RisersHalfords Group (HFD) 302.80p +13.83%Victrex (VCT) 1,400.00p +5.18%Rentokil Initial (RTO) 86.70p +4.46%Bwin.party Digital Entertainment (BPTY) 114.10p +4.39%Carillion (CLLN) 287.30p +3.72%Pace (PIC) 172.80p +3.60%Home Retail Group (HOME) 95.95p +3.23%International Personal Finance (IPF) 315.90p +3.03%New World Resources A Shares (NWR) 273.80p +2.89%Stobart Group Ltd. (STOB) 115.70p +2.84%FTSE 250 - FallersPetra Diamonds Ltd.(DI) (PDL) 113.80p -2.15%Afren (AFR) 139.30p -1.76%Brewin Dolphin Holdings (BRW) 170.00p -1.39%Brown (N.) Group (BWNG) 274.20p -1.19%JD Sports Fashion (JD.) 713.00p -0.97%Essar Energy (ESSR) 118.20p -0.92%Invensys (ISYS) 235.70p -0.88%Bovis Homes Group (BVS) 496.30p -0.84%RIT Capital Partners (RCP) 1,139.00p -0.78%Domino Printing Sciences (DNO) 566.00p -0.61%BC
More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.